Etomidate versus Ketamine as Prehospital Induction Agent in Patients with Suspected Severe Traumatic Brain Injury

AnesthesiologyPublished Retrospective analysis of a prospective observational cohort study

Authors' conclusion

The analysis found no evidence for an association between the use of etomidate or S(+)-ketamine as an anesthetic agent for intubation in patients with traumatic brain injury and mortality after 30 days in the prehospital setting

Study context

Population
Patients with suspected severe TBI transported to a participating trauma centre who received prehospital advanced airway management, Netherlandseligible for analysis
Participants
1,457 patients
Exposure
Etomidate vs S-ketamine for prehospital induction of anaesthesia
Outcome
Mortality
Follow-up
30 days
Methodological detailsBRAIN-PROTECT, multivariable logistic regression, inverse probability of treatment weighting
  • BRAIN-PROTECT
  • Multivariable logistic regression
  • Inverse probability of treatment weighting

Main finding

As reported in the abstract

30-day mortality
Etomidate vs S(+)-ketamineOdds ratio (95% CI)P value
Unadjusted; P = 0.716 for proportions
1.04(0.83–1.32)
P = 0.711
Adjusted for potential confounders
1.08(0.67–1.73)
P = 0.765
Etomidate vs S(+)-ketamineRisk difference (95% CI)P value
Adjusted for potential confounders
0.017(−0.051 to 0.084)
P = 0.686

Observational data: associations, not effects.

Further findings

30-day mortality in confirmed TBI and isolated TBI (planned subgroups)

No significant differences

Original publication

Etomidate versus Ketamine as Prehospital Induction Agent in Patients with Suspected Severe Traumatic Brain Injury. Anesthesiology. Published 8 January 2024. doi:10.1097/aln.0000000000004894

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.